Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study

Aims and objectives To examine changes in patient-reported fatigue, over a twelve month period, in rheumatoid arthritis patients who commence biologic treatment, and to identify possible predictors for such changes. Background Fatigue is a burdensome symptom for patients with rheumatoid arthritis. D...

Full description

Bibliographic Details
Main Authors: Hege Selheim Rinke, Clara Beate Gram Gjesdal, Heidi Markussen, Jörg Assmus, Gerd Karin Natvig
Format: Article
Language:English
Published: PeerJ Inc. 2019-04-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/6771.pdf
_version_ 1797424192842366976
author Hege Selheim Rinke
Clara Beate Gram Gjesdal
Heidi Markussen
Jörg Assmus
Gerd Karin Natvig
author_facet Hege Selheim Rinke
Clara Beate Gram Gjesdal
Heidi Markussen
Jörg Assmus
Gerd Karin Natvig
author_sort Hege Selheim Rinke
collection DOAJ
description Aims and objectives To examine changes in patient-reported fatigue, over a twelve month period, in rheumatoid arthritis patients who commence biologic treatment, and to identify possible predictors for such changes. Background Fatigue is a burdensome symptom for patients with rheumatoid arthritis. Despite biologics being effective in reducing disease activity, patients still report fatigue. Design A longitudinal observational study. Methods A total of 48 patients were enrolled in the study. Fatigue was measured by the Fatigue Severity Scale. Independent samples T-tests were used to test gender differences, and paired samples T-tests were used to measure differences between repeated measures. Bivariate and multiple regression analyses were used to examine potential predictors for changes in fatigue, such as age, sex, Disease Activity Score 28, pain and physical and emotional well-being. Results Forty-seven patients completed the study. From baseline to 12-month follow-up, fatigue decreased significantly in both women and men. Analyses of predictors were performed step-wise, and the final model included sex and physical well-being. The results from this final step showed that female sex was the only significant predictor for changes in fatigue. Conclusion Patients commencing biologic therapy reported a significant reduction in fatigue. Female sex was a significant predictor of changes in fatigue. Relevance to clinical practice Despite improvements in pharmacological treatment, patients with rheumatoid arthritis still report fatigue. This is a multifaceted health problem encompassing personal and emotional factors in addition to the clinical factors directly connected to the disease.
first_indexed 2024-03-09T07:58:43Z
format Article
id doaj.art-89ca65603adc4607b1249d1ca4e7e818
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T07:58:43Z
publishDate 2019-04-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-89ca65603adc4607b1249d1ca4e7e8182023-12-03T00:50:11ZengPeerJ Inc.PeerJ2167-83592019-04-017e677110.7717/peerj.6771Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal studyHege Selheim Rinke0Clara Beate Gram Gjesdal1Heidi Markussen2Jörg Assmus3Gerd Karin Natvig4Department of Rheumatology, Haukeland University Hospital, Bergen, NorwayDepartment of Rheumatology, Haukeland University Hospital, Bergen, NorwayDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, NorwayCentre for Clinical Research, Haukeland University Hospital, Bergen, NorwayDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, NorwayAims and objectives To examine changes in patient-reported fatigue, over a twelve month period, in rheumatoid arthritis patients who commence biologic treatment, and to identify possible predictors for such changes. Background Fatigue is a burdensome symptom for patients with rheumatoid arthritis. Despite biologics being effective in reducing disease activity, patients still report fatigue. Design A longitudinal observational study. Methods A total of 48 patients were enrolled in the study. Fatigue was measured by the Fatigue Severity Scale. Independent samples T-tests were used to test gender differences, and paired samples T-tests were used to measure differences between repeated measures. Bivariate and multiple regression analyses were used to examine potential predictors for changes in fatigue, such as age, sex, Disease Activity Score 28, pain and physical and emotional well-being. Results Forty-seven patients completed the study. From baseline to 12-month follow-up, fatigue decreased significantly in both women and men. Analyses of predictors were performed step-wise, and the final model included sex and physical well-being. The results from this final step showed that female sex was the only significant predictor for changes in fatigue. Conclusion Patients commencing biologic therapy reported a significant reduction in fatigue. Female sex was a significant predictor of changes in fatigue. Relevance to clinical practice Despite improvements in pharmacological treatment, patients with rheumatoid arthritis still report fatigue. This is a multifaceted health problem encompassing personal and emotional factors in addition to the clinical factors directly connected to the disease.https://peerj.com/articles/6771.pdfFatigueGenderRheumatoid arthritisFatigue severity scaleBiologic therapy
spellingShingle Hege Selheim Rinke
Clara Beate Gram Gjesdal
Heidi Markussen
Jörg Assmus
Gerd Karin Natvig
Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
PeerJ
Fatigue
Gender
Rheumatoid arthritis
Fatigue severity scale
Biologic therapy
title Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
title_full Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
title_fullStr Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
title_full_unstemmed Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
title_short Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
title_sort patient reported fatigue in patients with rheumatoid arthritis who commence biologic therapy a longitudinal study
topic Fatigue
Gender
Rheumatoid arthritis
Fatigue severity scale
Biologic therapy
url https://peerj.com/articles/6771.pdf
work_keys_str_mv AT hegeselheimrinke patientreportedfatigueinpatientswithrheumatoidarthritiswhocommencebiologictherapyalongitudinalstudy
AT clarabeategramgjesdal patientreportedfatigueinpatientswithrheumatoidarthritiswhocommencebiologictherapyalongitudinalstudy
AT heidimarkussen patientreportedfatigueinpatientswithrheumatoidarthritiswhocommencebiologictherapyalongitudinalstudy
AT jorgassmus patientreportedfatigueinpatientswithrheumatoidarthritiswhocommencebiologictherapyalongitudinalstudy
AT gerdkarinnatvig patientreportedfatigueinpatientswithrheumatoidarthritiswhocommencebiologictherapyalongitudinalstudy